< Back to companies

Welcome to Phyxiom. We are a digital platform that transforms the clinical outcomes for patients with uncontrolled asthma and COPD. Using data-driven insight and trend analysis, we give clinicians a perspective of personalised patient care, over and above standardised guidance. As a spin-out of the Royal College of Surgeons in Ireland (RCSI) we have over 10 years of evidence-based approach with demonstrable results. The platform incorporates a remote diagnostics platform, which is device independent, integrating smart inhalers and spirometry devices to patient data for time-based analysis. The platform acts as an intelligent decision support system for physicians delivering patient clinical data in an easily accessible form.

Share
Shareable draft
Get Involved in Phyxiom

Company Info

Founded
2021
Website
phyxiom.com/

Categories

Remote MonitoringDiagnostics & MonitoringClinical Decision SupportPulmonary/ Asthma

Disease Areas

Technologies

Remote MonitoringDecision SupportDevice IntegrationAnalytics
Only accessible to MedStartr community members. Join now

What do you think of Phyxiom?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Phyxiom
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free